Format

Send to

Choose Destination
Nat Rev Genet. 2006 Jul;7(7):537-51. Epub 2006 Jun 6.

Genetic defects in the human glycome.

Author information

1
Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, California 92037, USA. hudson@burnham.org

Erratum in

  • Nat Rev Genet. 2006 Aug;7(8):660.

Abstract

The spectrum of all glycan structures--the glycome--is immense. In humans, its size is orders of magnitude greater than the number of proteins that are encoded by the genome, one percent of which encodes proteins that make, modify, localize or bind sugar chains, which are known as glycans. In the past decade, over 30 genetic diseases have been identified that alter glycan synthesis and structure, and ultimately the function of nearly all organ systems. Many of the causal mutations affect key biosynthetic enzymes, but more recent discoveries point to defects in chaperones and Golgi-trafficking complexes that impair several glycosylation pathways. As more glycosylation disorders and patients with these disorders are identified, the functions of the glycome are starting to be revealed.

PMID:
16755287
DOI:
10.1038/nrg1894
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center